JPS61151116A - ５−（３−ｎ−ブチルオキサリルアミノフエニル）テトラゾ−ル含有医薬品組成物の製造法 - Google Patents

５−（３−ｎ−ブチルオキサリルアミノフエニル）テトラゾ−ル含有医薬品組成物の製造法

Info

Publication number
JPS61151116A
JPS61151116A JP59270939A JP27093984A JPS61151116A JP S61151116 A JPS61151116 A JP S61151116A JP 59270939 A JP59270939 A JP 59270939A JP 27093984 A JP27093984 A JP 27093984A JP S61151116 A JPS61151116 A JP S61151116A
Authority
JP
Japan
Prior art keywords
mtb
pharmaceutical composition
tetrazole
producing
butyloxalylaminophenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP59270939A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0528689B2 (enExample
Inventor
Yoshiaki Ogasawara
由明 小笠原
Shinji Kageyama
景山　真二
Toru Oguma
徹 小熊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wakamoto Pharmaceutical Co Ltd
Original Assignee
Wakamoto Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wakamoto Pharmaceutical Co Ltd filed Critical Wakamoto Pharmaceutical Co Ltd
Priority to JP59270939A priority Critical patent/JPS61151116A/ja
Priority to GB8519474A priority patent/GB2170403B/en
Priority to CH3336/85A priority patent/CH665637A5/fr
Priority to DE3530780A priority patent/DE3530780C2/de
Priority to US06/776,771 priority patent/US4778816A/en
Publication of JPS61151116A publication Critical patent/JPS61151116A/ja
Publication of JPH0528689B2 publication Critical patent/JPH0528689B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP59270939A 1984-12-24 1984-12-24 ５−（３−ｎ−ブチルオキサリルアミノフエニル）テトラゾ−ル含有医薬品組成物の製造法 Granted JPS61151116A (ja)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP59270939A JPS61151116A (ja) 1984-12-24 1984-12-24 ５−（３−ｎ−ブチルオキサリルアミノフエニル）テトラゾ−ル含有医薬品組成物の製造法
GB8519474A GB2170403B (en) 1984-12-24 1985-08-02 Medicament for treatment of asthma and preparation thereof
CH3336/85A CH665637A5 (fr) 1984-12-24 1985-08-02 5-(3-n-butyloxalylaminophenyl)tetrazole comme agent antiasthmatique, composition le contenant et procede de preparation de la composition.
DE3530780A DE3530780C2 (de) 1984-12-24 1985-08-28 Neue pharmazeutische Verwendung von 5-(3-n-Butyloxalylaminophenyl)-tetrazol
US06/776,771 US4778816A (en) 1984-12-24 1985-09-17 Anti-asthmatic composition and process for preparing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59270939A JPS61151116A (ja) 1984-12-24 1984-12-24 ５−（３−ｎ−ブチルオキサリルアミノフエニル）テトラゾ−ル含有医薬品組成物の製造法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP35812091A Division JPH0662411B2 (ja) 1991-12-27 1991-12-27 ５−（３−ｎ−ブチルオキサリルアミノフェニル）テトラゾール含有医薬品組成物の製造法

Publications (2)

Publication Number Publication Date
JPS61151116A true JPS61151116A (ja) 1986-07-09
JPH0528689B2 JPH0528689B2 (enExample) 1993-04-27

Family

ID=17493106

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59270939A Granted JPS61151116A (ja) 1984-12-24 1984-12-24 ５−（３−ｎ−ブチルオキサリルアミノフエニル）テトラゾ−ル含有医薬品組成物の製造法

Country Status (1)

Country Link
JP (1) JPS61151116A (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002540140A (ja) * 1999-03-25 2002-11-26 ビーエーエスエフ アクチェンゲゼルシャフト 固体医薬剤形のための粉末形態の可溶化賦形剤
US7514552B2 (en) 2003-05-30 2009-04-07 Asahi Kasei Chemicals Corporation Cellulose powder

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS591705A (ja) * 1982-06-27 1984-01-07 寺田　順治 留具を具えたネクタイ

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS591705A (ja) * 1982-06-27 1984-01-07 寺田　順治 留具を具えたネクタイ

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002540140A (ja) * 1999-03-25 2002-11-26 ビーエーエスエフ アクチェンゲゼルシャフト 固体医薬剤形のための粉末形態の可溶化賦形剤
JP4926319B2 (ja) * 1999-03-25 2012-05-09 ビーエーエスエフ ソシエタス・ヨーロピア 固体医薬剤形のための粉末形態の可溶化賦形剤
US7514552B2 (en) 2003-05-30 2009-04-07 Asahi Kasei Chemicals Corporation Cellulose powder

Also Published As

Publication number Publication date
JPH0528689B2 (enExample) 1993-04-27

Similar Documents

Publication Publication Date Title
AU603870B2 (en) Pharmaceutical composition, pharmaceutical granulate and process for their preparation
US4254099A (en) Pharmaceutical tablet composition
TW202112376A (zh) 一種含有布魯頓氏酪胺酸激酶抑制劑的口服固體錠劑及其製備方法
PT1051978E (pt) Composições de cefalosporina amorfa cristalograficamente estável e processo para a sua produção
TW201311236A (zh) 塞來昔布固體分散體及其製備方法
JP3518601B2 (ja) エバスタイムまたはその類似体に基づく医薬組成物
CA2055905C (en) Pharmaceutical composition comprising calcium polycarbophil
JP2002515421A (ja) レボチロキシンナトリウム含有医薬製剤
JPH0717866A (ja) 医薬組成物
JP2008540644A (ja) 新規粒質化方法及びそれから生成される粒質物
JPS61151116A (ja) ５−（３−ｎ−ブチルオキサリルアミノフエニル）テトラゾ−ル含有医薬品組成物の製造法
JP2003116966A (ja) 直接錠剤化用調合物および補助剤の調合方法
KR100267525B1 (ko) 시타라빈 옥포스페이트 경질 캡슐제
JPH04159222A (ja) 経口投与用固形薬剤の製造方法
DK175526B1 (da) Farmaceutisk præparat og fremgangsmåde til dets fremstilling
JPH10502937A (ja) フシジン酸錠剤の製法
JPS63107933A (ja) シヨ糖硫酸エステルアルミニウム塩製剤の製造法
JPS61200942A (ja) ビタミンＫ↓２−ジメチル−β−シクロデキストリン包接化合物
JPH05139973A (ja) ニフエジピン含有固形製剤の製造方法
JP2964195B2 (ja) ピロキシカム錠及びその製造法
JP2022112698A (ja) アピキサバン含有医薬組成物
CN113491695A (zh) 一种仑伐替尼药物组合物、其制备方法及应用
JPH0141125B2 (enExample)
CN118986905B (zh) 一种甲磺酸阿帕替尼片及其制备方法
JP2003160474A (ja) 難溶性薬物含有固形製剤の製造方法

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term